BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18326808)

  • 1. Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress.
    Chen YJ; Li J; Quilley J
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2305-12. PubMed ID: 18326808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat.
    Chen YJ; Li J; Quilley J
    Eur J Pharmacol; 2006 Jul; 541(1-2):80-6. PubMed ID: 16753143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats.
    Wang MH; Wang J; Chang HH; Zand BA; Jiang M; Nasjletti A; Laniado-Schwartzman M
    Am J Physiol Renal Physiol; 2003 Aug; 285(2):F295-302. PubMed ID: 12684227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat.
    Li J; Chen YJ; Quilley J
    J Pharmacol Exp Ther; 2005 Aug; 314(2):818-24. PubMed ID: 15879008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats.
    Rodriguez F; Lopez B; Perez C; Fenoy FJ; Hernandez I; Stec DE; Li Volti G; Salom MG
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1540-8. PubMed ID: 21849637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney.
    Quilley J; Chen YJ
    Hypertension; 2003 Oct; 42(4):837-43. PubMed ID: 12900435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
    Yousif MH; Benter IF; Dunn KM; Dahly-Vernon AJ; Akhtar S; Roman RJ
    Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
    Ito O; Omata K; Ito S; Hoagland KM; Roman RJ
    Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R822-30. PubMed ID: 11171663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contributions of cyclooxygenase- and cytochrome P450 omega-hydroxylase-dependent pathways to hypoxic dilation of skeletal muscle resistance arteries.
    Frisbee JC; Roman RJ; Krishna UM; Falck JR; Lombard JH
    J Vasc Res; 2001; 38(4):305-14. PubMed ID: 11455201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release.
    Chen YJ; Quilley J
    J Pharmacol Exp Ther; 2008 Feb; 324(2):658-63. PubMed ID: 17993607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-induced changes in blood flow in STZ-diabetic and non-diabetic rats: relation to nitric oxide synthase and cyclooxygenase inhibition.
    Granstam SO; Granstam E
    J Physiol Sci; 2011 Nov; 61(6):497-505. PubMed ID: 21881977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide in renal function in rats with short and prolonged periods of streptozotocin-induced diabetes.
    Suanarunsawat T; Klongpanichapak S; Chaiyabutr N
    Diabetes Obes Metab; 1999 Nov; 1(6):339-46. PubMed ID: 11225650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride.
    Oyekan AO; Youseff T; Fulton D; Quilley J; McGiff JC
    J Clin Invest; 1999 Oct; 104(8):1131-7. PubMed ID: 10525052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase.
    Cheng MK; McGiff JC; Carroll MA
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F474-9. PubMed ID: 12419775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats.
    Hoagland KM; Maier KG; Roman RJ
    Hypertension; 2003 Mar; 41(3 Pt 2):697-702. PubMed ID: 12623982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diabetic rats with a peroxynitrite decomposition catalyst prevents induction of renal COX-2.
    Chen YJ; Santos M; Quilley J
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H1125-32. PubMed ID: 21239635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy influence on the vascular interactions between nitric oxide and other endothelium-derived mediators in rat kidney.
    Bobadilla RA; Anguiano L; Pérez-Alvarez V; López Sanchez P
    Can J Physiol Pharmacol; 2003 Jan; 81(1):1-8. PubMed ID: 12665251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide.
    Guan Z; Willgoss DA; Matthias A; Manley SW; Crozier S; Gobe G; Endre ZH
    Acta Physiol Scand; 2003 Oct; 179(2):189-201. PubMed ID: 14510783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.